Hosted on MSN21d
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought
ATM, CDK12, and PALB2 genes, with a view to starting them on PARP inhibitor treatment. In 340 cases, the men's cancer had spread elsewhere (metastasized). Their average age was 69, but ranged ...
News Medical23d
Study challenges role of BRCA1 mutation in prostate cancer initiation
ATM, CDK12, and PALB2 genes, with a view to starting them on PARP inhibitor treatment. In 340 cases, the men's cancer had spread elsewhere (metastasised). Their average age was 69, but ranged ...